Author: OMN AI

AstraZeneca has reached a deal with Donald Trump’s administration to lower drug prices in exchange for tariff relief. The British pharmaceutical company agreed to sell several medicines at discounted rates to the US Medicaid program, which covers low-income Americans. In return, the White House will lift planned tariffs on the company’s products. Trump announced the agreement from the Oval Office, calling it part of his “most-favored-nation” pricing plan. “Americans have paid the highest prices in the world for prescription drugs,” he said. “That ends now.” AstraZeneca’s CEO, Pascal Soriot, said negotiations with the administration were “tough” but necessary. The company…

Duolingo has removed a sentence referencing author J.K. Rowling from its language learning platform after facing public criticism. The decision comes as part of the company’s efforts to respond to user concerns and maintain a welcoming, inclusive environment for all learners. The sentence, which appeared in certain exercises, drew backlash on social media from users who said it was insensitive. Duolingo’s move to remove the content reflects growing awareness among tech and educational platforms about the impact of controversial material on diverse user communities. Company representatives confirmed that the sentence was taken down promptly after concerns were raised. They emphasized…

The European Union has announced a new €1 billion initiative aimed at accelerating the adoption of artificial intelligence across critical industries. The program, unveiled by the European Commission, focuses on sectors including healthcare, manufacturing, energy, and defense. It represents a strategic push to strengthen technological sovereignty and improve Europe’s global competitiveness. The EU AI initiative is designed to support both public and private sector efforts in deploying advanced AI systems. By funding research, innovation, and implementation, the program seeks to ensure that European industries can leverage AI to improve efficiency, reduce costs, and create smarter solutions for societal challenges. Healthcare…

The largest banks in the United States are preparing to report stronger profits for the third quarter of 2025, fueled by a sharp rebound in investment banking activity. After a year of sluggish performance, renewed deal-making and capital market transactions are driving a much-needed recovery in earnings. Analysts expect the six biggest financial institutions—JPMorgan Chase, Bank of America, Citigroup, Goldman Sachs, Morgan Stanley, and Wells Fargo—to post higher revenues as corporate clients return to the markets. Mergers, acquisitions, and initial public offerings have increased over recent months, signaling renewed business confidence amid easing economic concerns. Industry experts say this surge…

The U.S. government has announced a new agreement with AstraZeneca that aims to reduce prescription drug costs for low-income Americans. The deal, revealed on October 10, 2025, will see the British pharmaceutical company supply several of its key medicines to Medicaid at significantly discounted prices. In exchange, AstraZeneca will receive a three-year exemption from import tariffs on its U.S. drug shipments. This U.S. drug-pricing deal marks one of the most notable public-private healthcare collaborations under the current administration. It is expected to lower financial barriers for millions of Americans who depend on Medicaid for essential medicines, including treatments for heart…

Only four bottles of Asahi Super Dry beer remain on the shelves of Ben Thai, a small restaurant in Sengawacho, a suburb of Tokyo. Owner Sakaolath Sugizaki hopes to receive more soon, but her supplier keeps most stock for larger clients. Cyber-attack halts production at Japan’s biggest brewer Asahi, Japan’s best-selling beer producer, halted production at most of its 30 factories last month after a major cyber-attack. All Japanese facilities, including six breweries, have since partially reopened. Yet, its computer systems remain down. The company now processes orders and shipments manually, relying on pen, paper and fax machines. Shipments have…

Donald Trump has warned he may impose 100% tariffs on Chinese imports from 1 November, accusing Beijing of “very hostile” actions over rare-earth export restrictions. The US president’s threat reignited fears of a renewed trade war between the world’s two largest economies, sending Wall Street tumbling. The S&P 500 dropped 2.7%, the Nasdaq 3.6%, and Nvidia shares nearly 5%. Trump said China’s decision to expand controls on rare-earth exports — materials vital for electric vehicles and aircraft — was an attempt to “hold the world captive.” “I never thought it would come to this,” he wrote on Truth Social. “But…

This report draws on the October 2025 Ami Magazine investigation by Riva Pomerantz, which revealed new legal documents and intelligence suggesting that UBS, one of the world’s largest banks, may still be linked to undisclosed Nazi-era accounts — decades after the 1998 Holocaust bank settlement. When Judge Edward Kormann approved that $1.25 billion restitution deal, the world believed the story was closed. But newly surfaced evidence — including sealed ledgers, witness statements, and intelligence files — suggests that the 1998 agreement may have concealed more than it resolved. The Accounts That Never Closed According to Israeli and U.S. sources, UBS,…

“This technology is our future threat,” warns Serhiy Beskrestnov as he inspects a recently captured Russian drone. Unlike conventional weapons, it uses artificial intelligence to identify and strike targets without human control. Beskrestnov, a consultant for Ukraine’s defence forces, has analysed countless drones since the invasion began. This one stands out. It neither sends nor receives signals, making it impossible to jam or detect. Both Ukrainian and Russian forces now experiment with AI on the battlefield. They use it to locate enemy positions, process intelligence, and clear mines faster than ever. Artificial intelligence becomes a frontline force AI has become…

Researchers at the University of East Anglia say they’ve developed the first reliable blood test for myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS). Currently, ME/CFS is diagnosed only through symptoms, often leaving patients undiagnosed or misdiagnosed for years. “This could transform how we diagnose and manage the disease,” said lead researcher Prof Dmitry Pshezhetskiy. The study, conducted with Oxford Biodynamics, found unique DNA-folding patterns in ME/CFS patients that distinguished them from healthy individuals. Testing 108 participants, scientists reported 92% sensitivity and 98% specificity — suggesting high accuracy. “This is a significant step forward,” Pshezhetskiy said. “We now have a simple,…